DD BIO Z AND DD BIO Z - TRANSPA

K093748 · Dental Direkt of Amerika UG (Haftungsbeschraenkt) · EIH · Feb 24, 2010 · Dental

Device Facts

Record IDK093748
Device NameDD BIO Z AND DD BIO Z - TRANSPA
ApplicantDental Direkt of Amerika UG (Haftungsbeschraenkt)
Product CodeEIH · Dental
Decision DateFeb 24, 2010
DecisionSESE
Submission TypeAbbreviated
Regulation21 CFR 872.6660
Device ClassClass 2

Intended Use

Dental Blanks made of DD Bio Z or DD Bio Z-transpa are dental materials (semifinished products) made of yttrium stabilized, presintered zirconium dioxide for milled production of crowns and bridges frameworks on commercial CAD/CAM systems or handoperated copy-milling machines. machines with outstanding biocompatibility and high resistance against tension and pressure. Dental Blanks made from DD Bio Z or DD Bio Ztranspa are indicated for crowns, multi-unit bridges and inlay bridges. Applications include both anterior and posterior bridges.

Device Story

DD Bio Z and DD Bio Z-transpa are yttrium-stabilized, presintered zirconium dioxide dental blanks. These semifinished materials are used by dental professionals in clinical or laboratory settings to fabricate crown and bridge frameworks. The blanks are processed using commercial CAD/CAM systems or hand-operated copy-milling machines to mill the final dental restorations. The device provides a biocompatible, high-strength material for dental prosthetics. The healthcare provider uses the milled output to restore patient dentition, potentially improving functional and aesthetic outcomes.

Clinical Evidence

No clinical data. Bench testing was performed to validate design requirements and ensure conformance with ANSI/ADA Specifications No. 69:1999 and ISO 6872:2008.

Technological Characteristics

Yttrium-stabilized, presintered zirconium dioxide dental blanks. Form factor: semifinished blocks for milling. Conforms to ANSI/ADA Specifications No. 69:1999 and ISO 6872:2008. No software or electronic components.

Indications for Use

Indicated for crowns, multi-unit bridges, and inlay bridges in anterior and posterior regions.

Regulatory Classification

Identification

Porcelain powder for clinical use is a device consisting of a mixture of kaolin, felspar, quartz, or other substances intended for use in the production of artificial teeth in fixed or removable dentures, of jacket crowns, facings, and veneers. The device is used in prosthetic dentistry by heating the powder mixture to a high temperature in an oven to produce a hard prosthesis with a glass-like finish.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Dental Direkt of Amerika UG (haftungsbeschraenkt), Spenge, Germany Page 1 of 2 # FEB 2 4 2010 | 510(k) Number: | K093748 | |----------------|---------| |----------------|---------| Date: #### 510(k) Summary November 23, 2009 DD Bio Z, DD Bio Z-transpa Porcelain powder for clinical use K072569 Metoxit CAM blanks (21 CFR 872.6660, Product Code EIH) K081263 H.C. Starck Ceramics StarCeram K051462 DENTSPLY International Cercon Base Submitter of 510(k) ﻪ ﺗ Dental Direkt of Amerika UG (haftungsbeschraenkt) Pappelweg 6 32139 Spenge Germany Contact Person Gerhard de Boer (General Manager) Tel 0049 / 5225-8 6319-0 Fax: 0049 / 5225-8 6319-99 Establishment Registration Pending Number Date Prepared Common name Trade Name of Device Powder, Porcelain Class II Classification name Classification Predicate Devices Device Description and Intended Use Dental Blanks made of DD Bio Z or DD Bio Z-transpa are dental materials (semifinished products) made of yttrium stabilized, presintered zirconium dioxide for milled production of crowns and bridges frameworks on commercial CAD/CAM systems or handoperated copy-milling machines. machines with outstanding biocompatibility and high resistance against tension and pressure. Dental Blanks made from DD Bio Z or DD Bio Ztranspa are indicated for crowns, multi-unit bridges and inlay bridges. Applications include both anterior and posterior bridges. {1}------------------------------------------------ Page 2 of 2 510(k) Number: K093748 Date: Clinical and Non-Clinical Dental Direkt of Amerika UG (haftungsbeschraenkt) Testing did not conduct, nor rely upon, clinical tests to determine substantial equivalence. Non-clinical testing was performed in order to validate the design against the company's specified design requirements, and to : assure conformance with the following voluntary design standards: ANSI ADA Specifications No. 69:1999 ISO 6872:2008 Risk Management The device has been designed to either completely eliminate or mitigate known health hazards associated with the use of the device. Health hazard risk reduction has been accomplished by rigorous application of a risk management program according to ISO 14971 "Medical devices - Application of risk management to medical devices". Technological characteristics The technological characteristics between the predicate and proposed devices are identical. There is no difference in fundamental scientific technology. They are made from the same materials and have the same intended use. Substantial Equivalence Dental Direkt of Amerika UG (haftungsbeschraenkt) Conclusion believes that DD Bio Z and DD Bio Z-transpa are as safe and effective as the predicate devices when used as instructed by knowledgeable and trained personnel, and are substantially equivalent to the legally marketed predicate devices. {2}------------------------------------------------ Image /page/2/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is often associated with medicine and healthcare. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged in a circular pattern around the symbol. ## DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002 Mr. Gerhard de Boer FEB 2 4 2010 General Manager Dental Direkt of Amerika UG (haftungsbeschraenkt) Pappelweg 6 32139 Spenge GERMANY Re: K093748 Trade/Device Name: DD Bio Z, DD Bio Z-transpa Regulation Number: 21CFR 872.6660 Regulation Name: Porcelain Powder for Clinical Use Regulatory Class: II Product Code: EIH Dated: January 29, 2010 Received: February 3, 2010 Dear Mr. de Boer: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ ### Page 2- Mr. de Boer Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely vours. Ph for Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health #### Enclosure {4}------------------------------------------------ Indications for Use # 510(k) Number (if known): 1093748 Device Name: DD Bio Z, DD Bio Z-transpa Indications for Use: : Dental Blanks made from DD Bio Z or DD Bio Z-transpa are indicated for crowns, multiunit bridges and inlay bridges. Applications include both anterior and posterior ridges. Prescription Use (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) RSBetz ms for Dr. K.P. Muly (Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices Page 1 of 1 510(k) Number: K093748 510(k) Premarket Notification
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...